Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
As of April 2025 Sanofi has a market cap of โฌ114.76 Billion. This makes Sanofi the world's 120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ114.76 B | -2.25% |
2024 | โฌ117.40 B | 4.07% |
2023 | โฌ112.81 B | -0.37% |
2022 | โฌ113.23 B | 2.09% |
2021 | โฌ110.92 B | 12.19% |
2020 | โฌ98.87 B | -12% |
2019 | โฌ112.36 B | 19.25% |
2018 | โฌ94.22 B | 4.74% |
2017 | โฌ89.96 B | -9.56% |
2016 | โฌ99.47 B | -3.06% |
2015 | โฌ102.61 B | 2.82% |
2014 | โฌ99.80 B | -2.27% |
2013 | โฌ102.12 B | 6.7% |
2012 | โฌ95.70 B | 25.21% |
2011 | โฌ76.43 B | 21.86% |
2010 | โฌ62.72 B | -13.6% |
2009 | โฌ72.59 B | 20.02% |
2008 | โฌ60.48 B | -28.99% |
2007 | โฌ85.18 B | -10.46% |
2006 | โฌ95.13 B | -8.4% |
2005 | โฌ103.86 B | 24.62% |
2004 | โฌ83.34 B | 89.64% |
2003 | โฌ43.94 B | 3.17% |
2002 | โฌ42.59 B |
On Apr 24th, 2025 the market cap of Sanofi was reported to be: